967 related articles for article (PubMed ID: 33761654)
1. Comorbidities' potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis.
Cheng S; Zhao Y; Wang F; Chen Y; Kaminga AC; Xu H
Medicine (Baltimore); 2021 Mar; 100(12):e24971. PubMed ID: 33761654
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
3. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis.
Honardoost M; Janani L; Aghili R; Emami Z; Khamseh ME
Cerebrovasc Dis; 2021; 50(2):132-140. PubMed ID: 33530081
[TBL] [Abstract][Full Text] [Related]
4. Features of severe COVID-19: A systematic review and meta-analysis.
Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
[TBL] [Abstract][Full Text] [Related]
5. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis.
Zhou Y; Yang Q; Chi J; Dong B; Lv W; Shen L; Wang Y
Int J Infect Dis; 2020 Oct; 99():47-56. PubMed ID: 32721533
[TBL] [Abstract][Full Text] [Related]
6. Cardio-Cerebrovascular Disease is Associated With Severity and Mortality of COVID-19: A Systematic Review and Meta-Analysis.
Yu JN; Wu BB; Yang J; Lei XL; Shen WQ
Biol Res Nurs; 2021 Apr; 23(2):258-269. PubMed ID: 32851851
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.
Yang J; Zheng Y; Gou X; Pu K; Chen Z; Guo Q; Ji R; Wang H; Wang Y; Zhou Y
Int J Infect Dis; 2020 May; 94():91-95. PubMed ID: 32173574
[TBL] [Abstract][Full Text] [Related]
8. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
9. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study.
Wang F; Cao J; Yu Y; Ding J; Eshak ES; Liu K; Mubarik S; Shi F; Wen H; Zeng Z; Bai J; Yu C
Int J Epidemiol; 2021 Jan; 49(6):1940-1950. PubMed ID: 33150437
[TBL] [Abstract][Full Text] [Related]
11. Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis.
Patel U; Malik P; Shah D; Patel A; Dhamoon M; Jani V
J Neurol; 2021 Jan; 268(1):240-247. PubMed ID: 32770412
[TBL] [Abstract][Full Text] [Related]
12. Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
Gao Y; Chen Y; Liu M; Niu M; Song Z; Yan M; Tian J
Epidemiol Infect; 2021 Feb; 149():e66. PubMed ID: 33583450
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and comorbidities: a systematic review and meta-analysis.
Gold MS; Sehayek D; Gabrielli S; Zhang X; McCusker C; Ben-Shoshan M
Postgrad Med; 2020 Nov; 132(8):749-755. PubMed ID: 32573311
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
[TBL] [Abstract][Full Text] [Related]
18. Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19: A systematic review and meta-analysis without cases duplication.
Wang Z; Deng H; Ou C; Liang J; Wang Y; Jiang M; Li S
Medicine (Baltimore); 2020 Nov; 99(48):e23327. PubMed ID: 33235096
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
20. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
